Utilization of Nanotechnology to Improve Bone Health in Osteoporosis Exploiting Nigella sativa and Its Active Constituent Thymoquinone
Authors:
- Javed AhmadJaved Ahmad
- Hassan A. AlbarqiHAHassan A. Albarqi
- Mohammad Zaki AhmadMohammad Zaki Ahmad
- Mohamed A. A. OrabiMOMohamed A. A. Orabi
- ShadabShadab
- Ritam BandopadhyayRitam Bandopadhyay
- Faraha AhmedFAFaraha Ahmed
- Mohammad Ahmed KhanMKMohammad Ahmed Khan
- Javed AhamadJAJaved Ahamad
- Awanish MishraAwanish Mishra
Open Access
- 1 November 2022
- journal article
- review article
- Published by MDPI AG in Bioengineering
- Vol. 9 (11) , 631
Abstract
Osteoporosis, a chronic bone disorder, is one of the leading causes of fracture and morbidity risk. Numerous medicinally important herbs have been evaluated for their efficacy in improving bone mass density in exhaustive preclinical and limited clinical studies. Nigella sativa L. has been used as local folk medicine, and traditional healers have used it to manage various ailments. Its reported beneficial effects include controlling bone and joint diseases. The present manuscript aimed to provide a sound discussion on the pharmacological evidence of N. sativa and its active constituent, thymoquinone, for its utility in the effective management of osteoporosis. N. sativa is reported to possess anti-IL-1 and anti-TNF-α-mediated anti-inflammatory effects, leading to positive effects on bone turnover markers, such as alkaline phosphatase and tartrate-resistant acid phosphatase. It is reported to stimulate bone regeneration by prompting osteoblast proliferation, ossification, and decreasing osteoclast cells. Thymoquinone from N. sativa has exhibited an antioxidant effect on bone tissue by reducing the FeNTA-induced oxidative stress. The present manuscript highlights phytochemistry, pharmacological effect, and the important mechanistic perspective of N. sativa and its active constituents for the management of osteoporosis. Further, it also provides sound discussion on the utilization of a nanotechnology-mediated drug delivery approach as a promising strategy to improve the therapeutic performance of N. sativa and its active constituent, thymoquinone, in the effective management of osteoporosis.Keywords
Funding Information
- Deanship of Scientific Research at Najran University, Saudi Arabia (NU/RC/MRC/11/4)
This publication has 118 references indexed in Scilit:
- Nigella Sativa reverses osteoporosis in ovariectomized ratsBMC Complementary and Alternative Medicine, 2014
- A review on therapeutic potential of Nigella sativa: A miracle herbAsian Pacific Journal of Tropical Biomedicine, 2013
- Nigella sativa: A Potential Antiosteoporotic AgentEvidence-Based Complementary and Alternative Medicine, 2012
- Preventive effects of thymoquinone in a rat periodontitis model: a morphometric and histopathological studyJournal of Periodontal Research, 2011
- Physiology of Bone LossRadiologic Clinics of North America, 2010
- Osteoprotective effect of extract from Achyranthes bidentata in ovariectomized ratsJournal of Ethnopharmacology, 2010
- Blueberry prevents bone loss in ovariectomized rat model of postmenopausal osteoporosisThe Journal of Nutritional Biochemistry, 2008
- The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone lossGut, 2005
- Maldaptation of the link between inflammation and bone turnover may be a key determinant of osteoporosisMedical Hypotheses, 2004
- Association between Oxidative Stress and Bone Mineral DensityBiochemical and Biophysical Research Communications, 2001